Compare PRTS & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRTS | DXR |
|---|---|---|
| Founded | 1995 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto & Home Supply Stores | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.1M | 59.0M |
| IPO Year | 2006 | 1995 |
| Metric | PRTS | DXR |
|---|---|---|
| Price | $0.65 | $11.36 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $0.50 | N/A |
| AVG Volume (30 Days) | ★ 556.0K | 8.9K |
| Earning Date | 05-07-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,446,345.00 |
| Revenue This Year | N/A | $44,935.22 |
| Revenue Next Year | $5.25 | $74.79 |
| P/E Ratio | ★ N/A | $33.83 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.37 | $7.57 |
| 52 Week High | $1.36 | $14.76 |
| Indicator | PRTS | DXR |
|---|---|---|
| Relative Strength Index (RSI) | 25.79 | 60.07 |
| Support Level | $0.64 | $9.28 |
| Resistance Level | $0.75 | $14.16 |
| Average True Range (ATR) | 0.06 | 0.85 |
| MACD | -0.03 | 0.11 |
| Stochastic Oscillator | 3.22 | 70.37 |
CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. It serves as an end-to-end solution for automotive repair and maintenance resources, offering a seamless online shopping experience that empowers drivers along every part of their journey. The company principally sells its products to individual consumers through its network of websites and online marketplaces. Its products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system.